five

Main Characteristics of Trials Evaluating New Oral Anticoagulants for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation.

收藏
NIAID Data Ecosystem2026-03-08 收录
下载链接:
https://figshare.com/articles/dataset/_Main_Characteristics_of_Trials_Evaluating_New_Oral_Anticoagulants_for_Stroke_Prevention_in_Patients_with_Nonvalvular_Atrial_Fibrillation_/1080708
下载链接
链接失效反馈
官方服务:
资源简介:
D, Dabigatran; R, Rivaroxaban; A, Apixaban; E, Edoxaban; N, number of patients; AF, atrial fibrillation; TIA, transient ischemic attack, TTR = time in therapeutic range (International normalized ratio 2.0 to 3.0); CHF, congestive heart failure; DM, diabetes mellitus; HTN, hypertension; CHADS2 indicates CHF, hypertension, age, diabetes mellitus, stroke. *  =  Stroke or TIA only.
创建时间:
2014-06-23
二维码
社区交流群
二维码
科研交流群
商业服务